CAPR
NASDAQ · Biotechnology
Capricor Therapeutics Inc
$8.92
+0.68 (+8.25%)
Analyst Consensus
Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+600.0% upside
Low Target
$34.96
Average Target
$62.44
High Target
$82.04
Current Price
$8.92
Current
$8.92
$8.92
Target
$62.44
$62.44
$34.96
$62.44 avg
$82.04
Scenario Analysis
Bear Case
$34.96
291.9%
Low target
Base Case
$62.44
+600.0%
Avg target
Bull Case
$82.04
+819.7%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$40.37
-77.9% from high
52-Week Low
$2.96
+201.4% from low
Target vs 52W High
$62.44
+54.7% vs high
Next Earnings Report
Nov 10, 2026 · After Market Close
2d
until earnings
EPS Est: $-0.44
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |